Diana Tait Selected Research

Mitomycin (Mitomycin-C)

2/2004

Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diana Tait Research Topics

Disease

18	Rectal Neoplasms (Rectal Cancer) 10/2023 - 02/2006
15	Neoplasms (Cancer) 03/2024 - 02/2006
7	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2004
3	Adenocarcinoma 01/2024 - 06/2008
3	Breast Neoplasms (Breast Cancer) 11/2020 - 03/2007
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2012 - 04/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 03/2016
1	COVID-19 01/2021
1	Carcinoma (Carcinomatosis) 10/2018
1	Pelvic Neoplasms 09/2017
1	Opportunistic Infections (Opportunistic Infection) 11/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2011
1	Brain Neoplasms (Brain Tumor) 12/2008
1	Neoplasm Metastasis (Metastasis) 12/2008
1	Sigmoid Neoplasms 01/2008
1	Margins of Excision 06/2006
1	Primitive Neuroectodermal Tumors (PNET) 05/2006
1	Pain (Aches) 04/2006
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2006
1	Fecal Incontinence 04/2006
1	Sudden Death 02/2006
1	Pulmonary Embolism 02/2006
1	Chest Pain (Chest Pains) 02/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2006
1	Colitis 02/2006
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 06/2005
1	Erythema 02/2004
1	Infections 02/2004
1	Diarrhea 02/2004
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2002

Drug/Important Bio-Agent (IBA)

5	Cetuximab (Erbitux)FDA Link 03/2016 - 05/2012
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016 - 02/2006
4	Capecitabine (Xeloda)FDA Link 01/2016 - 02/2006
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2013 - 09/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2013 - 09/2012
2	Fluorouracil (Carac)FDA LinkGeneric 07/2005 - 02/2004
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2024
1	Interleukin-4 (Interleukin 4)IBA 11/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2020
1	Circulating Tumor DNAIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Coenzyme A (CoA)IBA 09/2012
1	Oxidoreductases (Dehydrogenase)IBA 09/2012
1	Peptides (Polypeptides)IBA 12/2006
1	AntidiarrhealsIBA 04/2006
1	Leucovorin (Folinic Acid)FDA Link 07/2005
1	alpha-Tocopherol FDA Link 06/2005
1	Pentoxifylline (Trental)FDA LinkGeneric 06/2005
1	AntigensIBA 04/2004
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2004
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 09/2002
1	Prednisone (Sone)FDA LinkGeneric 09/2002
1	Methotrexate (Mexate)FDA LinkGeneric 09/2002
1	Melphalan (Alkeran)FDA LinkGeneric 09/2002
1	Vincristine (Oncovin)FDA LinkGeneric 09/2002

Therapy/Procedure

19	Radiotherapy 10/2023 - 06/2005
11	Therapeutics 03/2024 - 09/2002
11	Chemoradiotherapy 10/2018 - 02/2006
9	Neoadjuvant Therapy 01/2024 - 06/2006
7	Drug Therapy (Chemotherapy) 01/2017 - 04/2006
2	Induction Chemotherapy 11/2013 - 09/2011
2	Adjuvant Chemotherapy 07/2005 - 04/2004
1	Transjugular Intrahepatic Portasystemic Shunt 03/2024
1	Minimally Invasive Surgical Procedures 01/2021
1	Salvage Therapy 01/2017
1	Highly Active Antiretroviral Therapy (HAART) 11/2011
1	Combination Drug Therapy (Combination Chemotherapy) 03/2010
1	Autologous Transplantation 09/2002
1	Transplantation 09/2002
1	Maintenance Chemotherapy 09/2002